NCT02843607
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Cancer Institute in Fuda cancer hospital Guangzhou, Guangdong, China
Clinical trial condition
Carcinoma, Renal Cell
Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.
1,363 public trials
252 recruiting studies
Carcinoma, Renal Cell trial results
NCT00005799
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- University of Colorado Denver, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States
NCT01282463
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma of Renal Pelvis, +21 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Sacramento, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Francisco, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
NCT03699579
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
- Taipei Veterans General Hospital Taipei, Taiwan
Completed
Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma
NCT01339975
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma Renal Cell, +15 more
- Locations
-
- University Bordeaux Hospital Bordeaux, France
NCT02315755
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Gazi University Ankara, Besevler, Turkey (Türkiye)
- Abdurrahman Yurtaslan Onkoloji Hastanesi Ankara, Demetevler, Turkey (Türkiye)
- Marmara Üniversitesi Pendik Eğtim Araştırma Hastanesi Pendik, İ̇stanbul, Turkey (Türkiye)
- Hacettepe University School of Medicine, Department of Medical Oncology Ankara, Turkey (Türkiye)
NCT03744585
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Ipsen Central Contact Paris, France
NCT00005851
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States
- Baylor University Medical Center Dallas, Texas, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT00428220
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
- Locations
-
- Emory University, Winship Cancer Institute Atlanta, Georgia, United States
- Investigational Drug Service Atlanta, Georgia, United States
- The Emory Clinic Atlanta, Georgia, United States
- Loyola University Medical Center Maywood, Illinois, United States
NCT01026337
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States